Human Genome Epidemiology Literature Finder
Records 1 - 12 (of 12 Records) |
Query Trace: Neuroblastoma and Egfr[original query] |
---|
Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling. Molecular cancer therapeutics 2012 Feb 11 (2): 485-91. Chaft Jamie E, Arcila Maria E, Paik Paul K, Lau Christopher, Riely Gregory J, Pietanza M Catherine, Zakowski Maureen F, Rusch Valerie, Sima Camelia S, Ladanyi Marc, Kris Mark |
EGFR, PIK3CA and PTEN gene status and their protein product expression in neuroblastic tumours. Folia neuropathologica 2010 48 (4): 238-45. Izycka-Swieszewska Ewa, Brzeskwiniewicz Magdalena, Wozniak Agnieszka, Drozynska El?bieta, Grajkowska Wies?awa, Perek Danuta, Balcerska Anna, Klepacka Teresa, Limon Janu |
Detecting the spectrum of multigene mutations in non-small cell lung cancer by Snapshot assay. Chinese journal of cancer 2014 Jul 33 (7): 346-50. Su Jian, Zhang Xu-Chao, An She-Juan, Zhong Wen-Zhao, Huang Ying, Chen Shi-Liang, Yan Hong-Hong, Chen Zhi-Hong, Guo Wei-Bang, Huang Xiao-Sui, Wu Yi-Lo |
Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium. Cancer 2015 Feb 121 (3): 448-56. Villaruz Liza C, Socinski Mark A, Abberbock Shira, Berry Lynne D, Johnson Bruce E, Kwiatkowski David J, Iafrate A John, Varella-Garcia Marileila, Franklin Wilbur A, Camidge D Ross, Sequist Lecia V, Haura Eric B, Ladanyi Mark, Kurland Brenda F, Kugler Kelly, Minna John D, Bunn Paul A, Kris Mark |
Genetic alterations in lung adenocarcinoma with a micropapillary component. Molecular and clinical oncology 2016 Feb 4 (2): 195-200. Furukawa Masashi, Toyooka Shinichi, Ichimura Kouichi, Yamamoto Hiromasa, Soh Junichi, Hashida Shinsuke, Ouchida Mamoru, Shien Kazuhiko, Asano Hiroaki, Tsukuda Kazunori, Miyoshi Shinichi |
Role of RAS mutation status as a prognostic factor for patients with advanced colorectal cancer treated with first-line chemotherapy based on fluoropyrimidines and oxaliplatin, with or without bevavizumab: A retrospective analysis. Molecular and clinical oncology 2017 Mar 6 (3): 403-408. Garde Noguera Javier, Jantus-Lewintre Eloisa, Gil-Raga Mireia, Evgenyeva Elena, Maciá Escalante Sonia, Llombart-Cussac Antonio, Camps Herrero Carl |
Aberrant status and clinicopathologic characteristic associations of 11 target genes in 1,321 Chinese patients with lung adenocarcinoma. Journal of thoracic disease 2018 Jan 10 (1): 398-407. Zhao Mengnan, Zhan Cheng, Li Ming, Yang Xiaodong, Yang Xinyu, Zhang Yong, Lin Miao, Xia Yifeng, Feng Mingxiang, Wang Q |
MET or NRAS amplification is an acquired resistance mechanism to the third-generation EGFR inhibitor naquotinib. Scientific reports 2018 2 8 (1): 1955. Ninomiya Kiichiro, Ohashi Kadoaki, Makimoto Go, Tomida Shuta, Higo Hisao, Kayatani Hiroe, Ninomiya Takashi, Kubo Toshio, Ichihara Eiki, Hotta Katsuyuki, Tabata Masahiro, Maeda Yoshinobu, Kiura Katsuyu |
Human Papillomavirus Infection, p16 Expression and Genetic Alterations in Vietnamese Cervical Neuroendocrine Cancer. The Malaysian journal of medical sciences : MJMS 2019 11 26 (5): 151-157. Van Ta To, Nguyen Quang Ngoc, Truong Van-Long, Tran Toan Trung, Nguyen Hung Phi, Vuong Linh Di |
Undetectable RAS-Mutant Clones in Plasma: Possible Implication for Anti-EGFR Therapy and Prognosis in Patients With RAS-Mutant Metastatic Colorectal Cancer. JCO precision oncology 2020 10 4 . Bouchahda Mohamed, Saffroy Raphael, Karaboué Abdoulaye, Hamelin Jocelyne, Innominato Pasquale, Saliba Faouzi, Lévi Francis, Bosselut Nelly, Lemoine Antoinet |
Role of molecular testing for malignant pleural effusion in targeted therapy for advanced non-small cell lung cancer. Diagnostic cytopathology 2023 4 . Rixu Lin, Yida Li, Yi Lin, Wenyi Tian, Lei Jiang, Jianmin |
Evaluation of SNaPshot and Sanger sequencing for the detection of KRAS and NRAS mutations in a sample of Venezuelan patients with colorectal cancer. Ecancermedicalscience 2025 1 18 1797. Daniela Rodríguez-Carrascal, Rafael Puche, Mary Acosta, Carlos Darío Ramír |
- Page last reviewed:Feb 1, 2024
- Content source: